OUR PORTFOLIO COMPANIES
ActiveHealth Management is a leading population health management company delivering data analytics, evidence-based clinical decision support and targeted health and wellness programs to more than 20 million lives. Acquired by Aetna (NYSE: AET).Company Website
Angioscore designs, develops, manufactures and markets scoring balloon catheters to treat cardiovascular and peripheral artery diseases. Its AngioSculpt devices have been used in over 350,000 procedures worldwide. Acquired by Spectranetics (Nasdaq: SPNC).Company Website
Best Doctors is a global health solutions company serving 30 million members worldwide. Best Doctors works with the best 5% of doctors, ranked by impartial peer review, to help people get the right diagnosis and right treatment.Company Website
Caregiver Services is a leading provider of in-home assisted living and Medicare/Medicaid home health services in Florida. CSI also operates a growing network of Prescribed Pediatric Extended Care (PPEC) facilities through its Pediatric Services subsidiary.Company Website
Care Management Technologies is a behavioral health analytics company that delivers actionable information to payers, administrators and clinicians in order to improve quality of care and reduce costs. CMT’s evidence based behavioral health analytics and decision support tools help payers and providers better coordinate care for their costliest, most complex members.Company Website
Cohesive Technologies provided advanced sample extraction and liquid chromatography products that increase throughput, efficiency and detection limits during LC/MS/MS analysis for pharmaceutical, contract research and clinical diagnostics applications. Acquired by Thermo Fisher Scientific (NYSE: TMO).
Definity Health was a pioneer and national leader in consumer-driven health benefit programs which combine high deductible health plans with health savings accounts (HSAs). Nearly 17.4 million Americans were covered by HSA-eligible insurance plans in 2014. Acquired by UnitedHealth Group (NYSE: UNH).
Gamma Medica’s LumaGEM Molecular Breast Imaging (MBI) system plays an important role in the early detection of breast cancer in women with dense breast tissue. MBI has been shown to detect 4x more cancers than mammography in dense breast, with 50% fewer false positives versus other supplemental screening techniques.Company Website
HealthEdge provides next-generation, business-transforming technology products to the healthcare payor market. HealthEdge enables its customers to radically innovate, drastically reduce costs and efficiently address the business imperatives of the evolving healthcare economy.Company Website
HealthMine is a population health management company that goes beyond traditional health and wellness programs. HealthMine’s cloud-based Personal Clinical Engagement platform drives consumer engagement by integrating lifestyle, biometric and clinical health data from the member’s plan into a personalized health portal providing real time status updates and suggested health actions.Company Website
Mauna Kea manufactures and markets Cellvizio®, the world’s smallest microscope, which enables real time, in vivo cellular imaging during endoscopic procedures. Cellvizio’s ‘optical biopsy’ capability helps physicians more accurately detect early forms of disease and make treatment decisions more quickly. Exited via IPO (Euronext: MKEA).Company Website
PatientSafe is transforming care delivery through the convergence of consumer mobile technologies and enterprise clinical systems to drive measurable results across patient safety, clinical quality and care team effectiveness. PatientSafe’s smart point-of-care solutions deliver real-time patient data, care team collaboration and clinical communications in a timely, contextual way.Company Website
QualityMetric works with health care organizations and life sciences companies to measure and better understand health outcomes and well being from the patient’s point of view. QualityMetric’s SF™ Health Surveys and other patient-reported outcome tools provide scientifically valid assessments of physical and mental health. Acquired by Optum, a UnitedHealth Group company (NYSE: UNH).
Valera Pharmaceuticals focused on developing, acquiring and commercializing products to treat urology and endocrinology diseases and disorders. Its innovative drug delivery technology included a soft, compact and flexible hydrogel-based implant designed to release therapeutic agents at a controlled rate for up to 12 months. Acquired by Indevus Pharmaceuticals.
VersaMed developed portable, software-based, smart ventilators for respiratory care in a variety of settings. Its flagship product, the iVent 201, is an intensive-care grade ventilator designed to be compact and portable for use in hospitals (acute and sub-acute), emergency transport and the home. Acquired by GE Healthcare.